Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Biochim Biophys Acta. 2014 Jan 5;1840(8):2441–2451. doi: 10.1016/j.bbagen.2013.12.028

Figure 1.

Figure 1

A. A section through an early human coronary atherosclerotic lesion immunostained for versican illustrating marked accumulation of the ECM proteoglycan. B. Upper panel – These lesions frequently contain macrophages, as indicated by positive staining with antibody to CD68. Lower panel – Adjacent section immunostained for versican illustrating frequent colocalization of macrophage accumulation with versican. Sections kindly provided by Drs. Frank Kolodgie and Renu Virmani, CV Path Institute, Inc., Gaithersburg, MD.